| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 72, 808-813, Copyright © 1991 by Endocrine Society
ARTICLES |
PJ Kelly, JL Hopper, GT Macaskill, NA Pocock, PN Sambrook and JA Eisman
Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.
Genetic factors are major determinants of adult bone density, however, it is unknown how these effects may be mediated. Since bone mineral density is the net result of bone formation and bone resorption we studied biochemical indices of bone formation (serum osteocalcin) and resorption [fasting urinary calcium:creatinine (Ca/Crt) and hydroxyproline:creatinine (OH/Crt)] in adult female twins; 39 monozygotic (MZ) and 31 dizygotic (DZ) twin pairs (age, mean +/- SEM, MZ: 51.1 +/- 1.5 yrs; DZ: 46.5 +/- 1.5 yrs, P = NS). Of these subjects, 18 MZ twin pairs and 10 DZ twin pairs were postmenopausal. The MZ twin pair correlations (rMZ) for each index of bone turnover exceeded that between DZ pairs (rDZ), but this difference was only significant for osteocalcin (rMZ = 0.81, rDZ = 0.21, P less than 0.001). Similarly, in the postmenopausal group examined alone, the rMZ (r = 0.84) for serum osteocalcin was significantly greater than rDZ (r = -0.003, P less than 0.03). These osteocalcin data imply that 80% of the variance in serum osteocalcin could be explained by genetic factors. Although genetic effects on fasting urinary hydroxyproline:creatine and calcium:creatinine were not demonstrable, these indices may be less precise and specific. The data indicate that circulating osteocalcin, and therefore bone formation, is strongly genetically determined. These studies suggest at least one of the mechanisms of the genetic effect on bone mass relates to the regulation of bone turnover.
This article has been cited by other articles:
![]() |
Y. Kikuchi, T. Imakiire, M. Yamada, T. Saigusa, T. Hyodo, T. Kushiyama, K. Higashi, N. Hyodo, K. Yamamoto, S. Suzuki, et al. Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1593 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Garnero, F. Munoz, O. Borel, E. Sornay-Rendu, and P. D. Delmas Vitamin D Receptor Gene Polymorphisms Are Associated with the Risk of Fractures in Postmenopausal Women, Independently of Bone Mineral Density J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4829 - 4835. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Dick, A. Devine, and R. L. Prince Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E989 - E995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peacock, C. H. Turner, M. J. Econs, and T. Foroud Genetics of Osteoporosis Endocr. Rev., June 1, 2002; 23(3): 303 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Nemetz, M Toth, M A Garcia-Gonzalez, T Zagoni, J Feher, A S Pena, and Z Tulassay Allelic variation at the interleukin 1{beta} gene is associated with decreased bone mass in patients with inflammatory bowel diseases Gut, November 1, 2001; 49(5): 644 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Eisman Pharmacogenetics of the Vitamin D Receptor and Osteoporosis Drug Metab. Dispos., April 1, 2001; 29(4): 505 - 512. [Abstract] [Full Text] |
||||
![]() |
O. Tajima, N. Ashizawa, T. Ishii, H. Amagai, T. Mashimo, L. J. Liu, S. Saitoh, K. Tokuyama, and M. Suzuki Interaction of the effects between vitamin D receptor polymorphism and exercise training on bone metabolism J Appl Physiol, April 1, 2000; 88(4): 1271 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Mitchell, S. A. Cole, R. L. Bauer, S. J. Iturria, E. A. Rodriguez, J. Blangero, J. W. MacCluer, and J. E. Hixson Genes Influencing Variation in Serum Osteocalcin Concentrations Are Linked to Markers on Chromosomes 16q and 20q J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1362 - 1366. [Abstract] [Full Text] |
||||
![]() |
J. A. Eisman Genetics of Osteoporosis Endocr. Rev., December 1, 1999; 20(6): 788 - 804. [Abstract] [Full Text] |
||||
![]() |
T D Spector, R W Keen, N K Arden, N A Morrison, P J Major, T V Nguyen, P J Kelly, J R Baker, P N Sambrook, J S Lanchbury, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain BMJ, May 27, 1995; 310(6991): 1357 - 1360. [Abstract] [Full Text] |
||||
![]() |
P. Sambrook, J. Birmingham, P. Kelly, S. Kempler, T. Nguyen, N. Pocock, and J. Eisman Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin N. Engl. J. Med., June 17, 1993; 328(24): 1747 - 1752. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |